Investor · 1 deal
Every published round Regal took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Buildxact | Series A | 1 Feb 2022 | $18.5m | Lead | Shearwater Capital, Startup Daily (7 Feb 2022), Startup Daily (2 Feb 2022), iTnews, buildxact.com, Shearwater Capital portfolio |
Companies Regal has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Buildxact | 1 Feb 2022, Series A | 1 | 1 |
Fund closes reported for Regal, as distinct from the investments it has made.
Companies Regal has backed that another company then bought. An exit for the holding, not a deal Regal did.
Stories naming Regal. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Nexsen, a biotech developing rapid pregnancy diagnostics for GBS, has kicked off an IPO aiming for ASX listing by end of September; Regal is named as an earlier backer.
Share trading platform Superhero is demerging from crypto exchange Swyftx, its founders resuming control via a management buyout backed by earlier investors, as Swyftx contends with crypto downturn and repeated staff cuts.
Ignition Lane's weekly tech roundup: AirTree raises $700m across three new funds, dozens of Australian startups announce rounds, a wave of acquisitions including Block completing its Afterpay buy, plus Web3 commentary and US market moves.
Also SmartCompany·SmartCompany·SmartCompany·Startup Daily·Startup Daily·SmartCompany·Startup Daily·SmartCompany·SmartCompany·Startup Daily·Startup Daily·Startup Daily·Startup Daily·Startup Daily·Startup Daily·Startup Daily·Startup Daily·Startup Daily·Startup Daily·Startup Daily
AFR healthcare and fitness section roundup: Early Bird raised $2 million led by Hyper Ventures; Resmed sold MatrixCare; Radiopharm seeks $16 million; plus Mayne Pharma, Healthscope, Sigma and policy stories.
Also SmartCompany